Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Millennium Pharmacon International TbkISX:SDPC 79 Net Current Asset Value is Rp69.05 as of Mar. 2026, which is 100% below its 10-year median of 1.29. GuruFocus rates ISX:SDPC with a GF Score™ of 79/100 and a GF Value™ of Rp166.83 (Fairly Valued). The stock has 5 warning signs investors should review. Among 77 Medical Distribution companies, PT Millennium Pharmacon International Tbk ranks better than 59.74% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
ISX:SDPC'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0.5 Med: 1.29 Max: 3.63
Current: 2.62
During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of PT Millennium Pharmacon International Tbk was 3.63. The lowest was 0.50. And the median was 1.29.
ISX:SDPC's Price-to-Net-Current-Asset-Value is ranked better than 59.74% of 77
companies
in the Medical Distribution industry
Industry Median: 3.19
vs ISX:SDPC: 2.62
PT Millennium Pharmacon International Tbk (ISX:SDPC) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
PT Millennium Pharmacon International Tbk Net Current Asset Value Related Terms
PT Millennium Pharmacon International Tbk Net Current Asset Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Millennium Pharmacon International Tbk Net Current Asset Value Chart
PT Millennium Pharmacon International Tbk Annual Data
ISX:SDPC vs MCK, COR, CAH: Net Current Asset Value Comparison
For the Medical Distribution subindustry, PT Millennium Pharmacon International Tbk's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Millennium Pharmacon International Tbk Price-to-Net-Current-Asset-Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Millennium Pharmacon International Tbk's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where PT Millennium Pharmacon International Tbk's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of Rp69.05 mean?
PT Millennium Pharmacon International Tbk (ISX:SDPC) has a Net Current Asset Value of Rp69.05 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on PT Millennium Pharmacon International Tbk and its competitors. This is 5253% above median its historical median of 1.29. Over the past decade, PT Millennium Pharmacon International Tbk's Net Current Asset Value has ranged from 0.50 to 3.63. According to the industry distribution chart, PT Millennium Pharmacon International Tbk ranks #31 out of 77 companies in the Medical Distribution industry, placing it in the top 40.3%.
Is PT Millennium Pharmacon International Tbk's Net Current Asset Value too high?
PT Millennium Pharmacon International Tbk's current Net Current Asset Value of Rp69.05 is 5253% above median its 10-year median of 1.29. Over the past 10 years, this metric has ranged from a low of 0.50 to a high of 3.63. Based on the distribution chart, PT Millennium Pharmacon International Tbk ranks #31 out of 77 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, PT Millennium Pharmacon International Tbk has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Millennium Pharmacon International Tbk's Net Current Asset Value compare to MCK and COR?
According to the Medical Distribution industry distribution chart, PT Millennium Pharmacon International Tbk ranks #31 out of 77 companies for Net Current Asset Value. This puts PT Millennium Pharmacon International Tbk in the upper half of its industry. The industry median Net Current Asset Value is 3.19. Historically, PT Millennium Pharmacon International Tbk's own Net Current Asset Value has ranged from 0.50 to 3.63 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Distribution company?
The median Net Current Asset Value among Medical Distribution companies is 3.19, based on 77 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on PT Millennium Pharmacon International Tbk and its competitors. For the Medical Distribution industry, the median Net Current Asset Value is 3.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Millennium Pharmacon International Tbk's current Net Current Asset Value is Rp69.05, which is 5253% above median its own 10-year median of 1.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Millennium Pharmacon International Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Millennium Pharmacon International Tbk (ISX:SDPC) is currently considered Fairly Valued. The stock's GF Value™ is Rp166.83, compared to a current price of Rp181.00 — trading 8.5% above its estimated fair value. The current Net Current Asset Value is Rp69.05, which is 5253% above median its 10-year median of 1.29. PT Millennium Pharmacon International Tbk's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For PT Millennium Pharmacon International Tbk (ISX:SDPC), the current Net Current Asset Value is Rp69.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Millennium Pharmacon International Tbk (ISX:SDPC) Overvalued in 2026?
Based on GuruFocus' analysis, PT Millennium Pharmacon International Tbk stock appears to be overvalued.
The current stock price of Rp181.00 is trading 8.5% above its estimated GF Value™ of Rp166.83.
GuruFocus considers PT Millennium Pharmacon International Tbk to be Fairly Valued.
Key valuation signals for ISX:SDPC:
Net Current Asset Value: Rp69.05 (5253% above median its 10-year median of 1.29)
GF Value™: Rp166.83 vs. price of Rp181.00 (8.5% above fair value)
No single metric tells the full story. See the ISX:SDPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddressJl. Sultan Iskandar Muda No 18/Jl. Bungur No. 1, Crown Bungur Arteri Lantai 2-4, Kel. Kebayoran Lama Selatan, Kec. Kebayoran Lama, South Jakarta, Jakarta, IDN, 12240
PT Millennium Pharmacon International Tbk is engaged in distributing medicines, food supplements, and medical disposables. The group's operating segments are Prescription medicine, Non-prescription medicine, Medical Disposables, and others, of which the majority of revenue is derived from the Prescription Medicine segment. The company's geographical segments are Jawa, Sumatra, Kalimantan, Sulawesi, and Bali & Lombok.
79GF Score
Get the complete analysis for ISX:SDPC
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SDPC has been successfully added to your 
